HuGE Literature Finder
Records
1
-
3
Outcome Definition Influences the Relationship Between Genetic Polymorphisms of ERCC1, ERCC2, SLC22A2 and Cisplatin Nephrotoxicity in Adult Testicular Cancer Patients. Genes 2019 May 10 (5): . Zazuli Zulfan, Otten Leila S, Drögemöller Britt I, Medeiros Mara, Monzon Jose G, Wright Galen E B, Kollmannsberger Christian K, Bedard Philippe L, Chen Zhuo, Gelmon Karen A, McGoldrick Nicole, Kitchlu Abhijat, Vijverberg Susanne J H, Masereeuw Rosalinde, Ross Colin J D, Liu Geoffrey, Carleton Bruce C, Maitland-van der Zee Anke |
Association Study Among Candidate Genetic Polymorphisms and Chemotherapy-Related Severe Toxicity in Testicular Cancer Patients. Frontiers in pharmacology 2019 10 206. Lavanderos María A, Cayún Juan P, Roco Ángela, Sandoval Christopher, Cerpa Leslie, Rubilar Juan C, Cerro Roberto, Molina-Mellico Sebastián, Celedón Cesar, Cerda Berta, García-Martín Elena, Agúndez José A G, Acevedo Cristián, Peña Karina, Cáceres Dante D, Varela Nelson M, Quiñones Luis |
Polymorphisms in RAI and in genes of nucleotide and base excision repair are not associated with risk of testicular cancer. Cancer letters 2005 Jul 225 (2): 245-51. Laska Magdalena J, Nexø Bjørn A, Vistisen Kirsten, Poulsen Henrik Enghusen, Loft Steffen, Vogel Ul |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 03, 2022
- Content source: